BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 29427322)

  • 1. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients.
    Lewis JD; Barros AJ; Sifri CD
    Transpl Infect Dis; 2018 Jun; 20(3):e12856. PubMed ID: 29427322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-center experience with infections due to daptomycin-nonsusceptible Enterococcus faecium in liver transplant recipients.
    Lewis JD; Enfield KB; Cox HL; Mathers AJ; Sifri CD
    Transpl Infect Dis; 2016 Jun; 18(3):341-53. PubMed ID: 26953719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perioperative daptomycin for prophylaxis of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
    Mak JT; Ha S; Perloff S; Knorr JP
    Transpl Infect Dis; 2024 Feb; 26(1):e14186. PubMed ID: 37910593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daptomycin nonsusceptible vancomycin resistant Enterococcus bloodstream infections in patients with hematological malignancies: risk factors and outcomes.
    Herc ES; Kauffman CA; Marini BL; Perissinotti AJ; Miceli MH
    Leuk Lymphoma; 2017 Dec; 58(12):2852-2858. PubMed ID: 28402152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin perioperative prophylaxis for the prevention of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients.
    Sarwar S; Koff A; Malinis M; Azar MM
    Transpl Infect Dis; 2020 Jun; 22(3):e13280. PubMed ID: 32216015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Enterococcal Bacteremia in Liver Transplant Recipients.
    Kim YJ; Jun YH; Choi HJ; You YK; Kim DG; Choi JY; Yoon SK; Kim SI
    Transplant Proc; 2019 Oct; 51(8):2766-2770. PubMed ID: 31493916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.
    Judge T; Pogue JM; Marchaim D; Ho K; Kamatam S; Parveen S; Tiwari N; Nanjireddy P; Bheemreddy S; Biedron C; Reddy SM; Khammam V; Chalana IK; Tumma RS; Collins V; Yousuf A; Lephart PR; Martin ET; Rybak MJ; Kaye KS; Hayakawa K
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1250-4. PubMed ID: 23143365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection.
    Lee IK; Sng YP; Li WF; Chen CL; Wang CC; Lin CC; Chen IL
    J Chemother; 2022 Oct; 34(6):367-374. PubMed ID: 35075978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L.
    Chong PP; van Duin D; Bangdiwala A; Ivanova A; Miller WC; Weber DJ; Gilligan PH; Shea TC
    Clin Ther; 2016 Nov; 38(11):2468-2476. PubMed ID: 27771176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients.
    Banach DB; Peaper DR; Fortune BE; Emre S; Dembry LM
    Clin Transplant; 2016 Mar; 30(3):306-11. PubMed ID: 26780305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an
    Belley A; Arhin FF; Moeck G
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29109163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-resistant enterococci infection and predisposing factors for infection and mortality in patients with acute leukaemia and febrile neutropenia.
    Kirkizlar TA; Akalin H; Kirkizlar O; Ozkalemkas F; Ozkocaman V; Kazak E; Ozakin C; Bulbul EN; Ozboz ES; Ali R
    Leuk Res; 2020 Dec; 99():106463. PubMed ID: 33130331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation
    Kunz Coyne AJ; Stamper K; El Ghali A; Kebriaei R; Biswas B; Wilson M; Deschenes MV; Tran TT; Arias CA; Rybak MJ
    Microbiol Spectr; 2023 Aug; 11(4):e0034023. PubMed ID: 37338375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2017 Apr; 64(8):1026-1034. PubMed ID: 28329222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
    Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
    Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
    Britt NS; Potter EM; Patel N; Steed ME
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of subclinical transmission of vancomycin-resistant enterococcus within an intensive care unit in Taiwan.
    Lee SC; Lee CW; Shih TC; See LC; Chu CM; Liu YC
    J Microbiol Immunol Infect; 2016 Oct; 49(5):749-759. PubMed ID: 27156242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
    Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.